Treatment of urethral syndrome with triamcinolone acetonide.
A new method for the treatment of the urethral syndrome is presented. Therapy involves the submucosal injection of triamcinolone acetonide around Skene's glands to decrease inflammation and scarring. It is a simple office procedure, while all other therapeutic modalities are surgical.
D002908:Chronic Disease; D003556:Cystitis / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007267:Injections; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D014526:Urethritis / Q000188:drug therapy*; D014555:Urination Disorders / Q000188:drug therapy
D014222:Triamcinolone Acetonide